

Obstructive sleep apnoea increases risk of all-cause mortality.1 In 2019, the global burden of obstructive sleep apnoea was estimated at nearly 1 billion adults.2 However, guidance regarding the future burden of the condition, important to developing policy and public health strategies, is scarce. An innovative modelling study by Elroy Boers and colleagues3 in The Lancet Respiratory Medicine now provides robust data regarding the inferred 30-year burden of obstructive sleep apnoea in the USA. A major strength of their analysis is the probabilistic simulation model, accounting for risk factors such as age, sex, and BMI.
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet
Respiratory Medicine
|15th Jan, 2026
|The Lancet